News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Daily News Cardiosave IABPs—Yet Again—the Subject of a Class I Recall: FDA Caitlin E. Cox August 17, 2023
News Daily News Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA Michael O'Riordan August 10, 2023